Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis
Ariele L. Greenfield, … , Michael R. Wilson, H.-Christian von Büdingen
Ariele L. Greenfield, … , Michael R. Wilson, H.-Christian von Büdingen
Published February 12, 2019
Citation Information: JCI Insight. 2019;4(6):e126599. https://doi.org/10.1172/jci.insight.126599.
View: Text | PDF
Research Article Immunology Neuroscience

Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis

  • Text
  • PDF
Abstract

B cells are key contributors to chronic autoimmune pathology in multiple sclerosis (MS). Clonally related B cells exist in the cerebrospinal fluid (CSF), meninges, and CNS parenchyma of MS patients. We sought to investigate the presence of clonally related B cells over time by performing Ig heavy chain variable region repertoire sequencing on B cells from longitudinally collected blood and CSF samples of MS patients (n = 10). All patients were untreated at the time of the initial sampling; the majority (n = 7) were treated with immune-modulating therapies 1.2 (±0.3 SD) years later during the second sampling. We found clonal persistence of B cells in the CSF of 5 patients; these B cells were frequently Ig class-switched and CD27+. Specific blood B cell subsets appear to provide input into CNS repertoires over time. We demonstrate complex patterns of clonal B cell persistence in CSF and blood, even in patients on immune-modulating therapy. Our findings support the concept that peripheral B cell activation and CNS-compartmentalized immune mechanisms can in part be therapy resistant.

Authors

Ariele L. Greenfield, Ravi Dandekar, Akshaya Ramesh, Erica L. Eggers, Hao Wu, Sarah Laurent, William Harkin, Natalie S. Pierson, Martin S. Weber, Roland G. Henry, Antje Bischof, Bruce A.C. Cree, Stephen L. Hauser, Michael R. Wilson, H.-Christian von Büdingen

×

Figure 1

Persistent CSF Ig-VH clusters are present in MS patients.

Options: View larger image (or click on image) Download as PowerPoint
Persistent CSF Ig-VH clusters are present in MS patients.
Shown are the ...
Shown are the numbers of Ig-VH clusters within CSF (blue circles) and PB (red circles) at T1 and T2. Circle overlap values, Ig-VH clusters found in both CSF and PB at T1 or T2; nonoverlap circle values, Ig-VH clusters exclusively found in CSF or PB, not both. Arrows, of total Ig-VH clusters in CSF or PB (nonoverlap portion of circle + circle overlap), the number of Ig-VH clusters that are present at both T1 and T2. Patients (Pts) 1–5 have persistent CSF Ig-VH clusters; Pts 6–10 did not have identifiable persistent CSF Ig-VH clusters.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts